Skip to main content
OpenTrials

Clinical trial condition

Cytomegalovirus Infections

Explore clinical trials studying Cytomegalovirus Infections. Study availability and eligibility vary by location and protocol.

284 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Cytomegalovirus Infections trial results

Completed

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

NCT02396134

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients

NCT02103426

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +5 more
Locations
  • Site US10009 Los Angeles, California, United States
  • Site US10003 Orlando, Florida, United States
  • Site US10001 Baltimore, Maryland, United States
  • Site US10004 Houston, Texas, United States
View Trial Details
Completed

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

NCT01649869

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +12 more
Locations
  • Children's of Alabama Child Health Research Unit (CHRU) Birmingham, Alabama, United States
  • Children's National Medical Center - Sheikh Zayed Campus - Infectious Disease Washington D.C., District of Columbia, United States
  • Washington University School of Medicine in St. Louis - Center for Clinical Studies St Louis, Missouri, United States
  • Steven and Alexandra Cohen Childrens Medical Center of New York - New Hyde Park - Infectious Disease Manhasset, New York, United States
View all 18 locations
View Trial Details
Completed

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

NCT03930615

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • City of Hope National Medical Center ( Site 0158) Duarte, California, United States
  • University of California Davis Medical Center ( Site 0156) Sacramento, California, United States
  • University of Miami, Sylvester Comprehensive Cancer Center ( Site 0160) Miami, Florida, United States
  • Indiana Blood and Marrow Transplantation ( Site 0175) Indianapolis, Indiana, United States
View all 32 locations
View Trial Details
Completed

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

NCT03940586

Conditions
Cytomegalovirus (CMV) Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • City of Hope Comprehensive Cancer Center ( Site 0251) Duarte, California, United States
  • Children's Hospital of Orange County ( Site 0241) Orange, California, United States
  • UCSF Benioff Children's Hospital San Francisco ( Site 0245) San Francisco, California, United States
  • University Of Chicago School Of Medicine ( Site 0253) Chicago, Illinois, United States
View all 40 locations
View Trial Details
Completed

MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)

NCT04129398

Conditions
Cytomegalovirus Disease, Cytomegalovirus Infection, Cytomegalovirus Infections, +4 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital ( Site 0002) Nagoya, Aichi-ken, Japan
  • Sapporo City General Hospital ( Site 0004) Sapporo, Hokkaido, Japan
  • Osaka University Hospital ( Site 0003) Suita, Osaka, Japan
  • Tokyo Women's Medical University Hospital ( Site 0001) Tokyo, Japan
View Trial Details

Related conditions